IMPACT OF CANCER DIAGNOSIS ON SSI INCIDENCE

a 2025

IMPACT OF CANCER DIAGNOSIS ON SSI INCIDENCE

VEVERKOVÁ, Lenka; Petr DOLEŽAL; Jakub HABR; Petr VLČEK; Jan ŽÁK et al.

Základní údaje

Originální název

IMPACT OF CANCER DIAGNOSIS ON SSI INCIDENCE

Autoři

VEVERKOVÁ, Lenka; Petr DOLEŽAL; Jakub HABR; Petr VLČEK; Jan ŽÁK; Michal REŠKA; Igor PENKA a Jan KONEČNÝ

Vydání

2025

Další údaje

Jazyk

angličtina

Typ výsledku

Konferenční abstrakt

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Španělsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Označené pro přenos do RIV

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

oncological diagnosis significant factor SSI

Změněno: 2. 2. 2026 14:48, Mgr. Eva Suchánková

Anotace

V originále

The aim of this study was to analyse the incidence of surgical site infections (SSIs) in patients undergoing surgery over a ten-year period and to compare it with that in patients diagnosed with cancer. Method: A retrospective analysis was performed using data from the Hospital Information System (HIS), focusing on patients who underwent surgery for a primary diagnosis of cancer. A total of 26,486 patients were included in the analysis, of whom 2,298 had an oncological diagnosis. Statistical significance was assessed at a level of 0.05 using t-tests, examining variables such as age, diagnosis, type of surgery, length of hospital stay and incidence of SSI. Results / Discussion: The results showed that the incidence of SSI was 2-3 times higher in cancer patients compared to non-cancer patients. The confidence intervals ranged from 2.83% to 6.36%, suggesting that there is a 95% probability that cancer patients have a significantly increased risk of developing an SSI. Age was not identified as a statistically significant factor for the occurrence of infections; however, SSIs led to longer hospital stays in both oncological and non-oncological patients. Conclusion: These findings confirm that oncological diagnosis is a significant factor influencing SSI incidence and highlight the need for targeted prevention and infection management strategies in this population. We recommend further research into specific factors that may increase the risk of SSI in cancer patients and interventions that may reduce these infections. The results of this study may contribute to improved patient care and reduced morbidity associated with surgical procedures in cancer patients.

Návaznosti

MUNI/A/1692/2024, interní kód MU

Název: Ovlivnění strategie chirurgické léčby u komplikovaných operací II

Investor: Masarykova univerzita, Ovlivnění strategie chirurgické léčby u komplikovaných operací II

Citovat

VEVERKOVÁ, Lenka; Petr DOLEŽAL; Jakub HABR; Petr VLČEK; Jan ŽÁK; Michal REŠKA; Igor PENKA a Jan KONEČNÝ. IMPACT OF CANCER DIAGNOSIS ON SSI INCIDENCE. 2025.

@proceedings{2487598,
   author = {Veverková, Lenka and Doležal, Petr and Habr, Jakub and Vlček, Petr and Žák, Jan and Reška, Michal and Penka, Igor and Konečný, Jan},
   keywords = {oncological diagnosis significant factor SSI},
   language = {eng},
   title = {IMPACT OF CANCER DIAGNOSIS ON SSI INCIDENCE},
   url = {https://apps.m-anage.com/ewmagneaupp2025/en-GB/pag/},
   year = {2025}
}

TY  - CONF
ID  - 2487598
AU  - Veverková, Lenka - Doležal, Petr - Habr, Jakub - Vlček, Petr - Žák, Jan - Reška, Michal - Penka, Igor - Konečný, Jan
PY  - 2025
TI  - IMPACT OF CANCER DIAGNOSIS ON SSI INCIDENCE
KW  - oncological diagnosis significant factor SSI
UR  - https://apps.m-anage.com/ewmagneaupp2025/en-GB/pag/
N2  - The aim of this study was to analyse the incidence of surgical site infections (SSIs) in patients undergoing surgery over a ten-year period and to compare it with that in patients diagnosed with cancer. Method: A retrospective analysis was performed using data from the Hospital Information System (HIS), focusing on patients who underwent surgery for a primary diagnosis of cancer. A total of 26,486 patients were included in the analysis, of whom 2,298 had an oncological diagnosis. Statistical significance was assessed at a level of 0.05 using t-tests, examining variables such as age, diagnosis, type of surgery, length of hospital stay and incidence of SSI. Results / Discussion: The results showed that the incidence of SSI was 2-3 times higher in cancer patients compared to non-cancer patients. The confidence intervals ranged from 2.83% to 6.36%, suggesting that there is a 95% probability that cancer patients have a significantly increased risk of developing an SSI. Age was not identified as a statistically significant factor for the occurrence of infections; however, SSIs led to longer hospital stays in both oncological and non-oncological patients. Conclusion: These findings confirm that oncological diagnosis is a significant factor influencing SSI incidence and highlight the need for targeted prevention and infection management strategies in this population. We recommend further research into specific factors that may increase the risk of SSI in cancer patients and interventions that may reduce these infections. The results of this study may contribute to improved patient care and reduced morbidity associated with surgical procedures in cancer patients.
ER  -

VEVERKOVÁ, Lenka; Petr DOLEŽAL; Jakub HABR; Petr VLČEK; Jan ŽÁK; Michal REŠKA; Igor PENKA a Jan KONEČNÝ. \textit{IMPACT OF CANCER DIAGNOSIS ON SSI INCIDENCE}. 2025.

Přehled o publikaci